Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG Jr, Pinedo HM.
Vermorken JB, et al. Among authors: scheper rj.
Lancet. 1999 Jan 30;353(9150):345-50. doi: 10.1016/S0140-6736(98)07186-4.
Lancet. 1999.
PMID: 9950438
Clinical Trial.